Show simple item record

dc.contributor.authorWhite, B
dc.contributor.authorRafiq, M
dc.contributor.authorGonzalez-Izquierdo, A
dc.contributor.authorHamilton, W
dc.contributor.authorPrice, S
dc.contributor.authorLyratzopoulos, G
dc.date.accessioned2022-03-02T10:47:21Z
dc.date.issued2022-02-18
dc.date.updated2022-03-01T17:07:13Z
dc.description.abstractBACKGROUND: The management of adults presenting with fatigue presents a diagnostic challenge, particularly regarding possible underlying cancer. METHODS: Using electronic health records, we examined cancer risk in patients presenting to primary care with new-onset fatigue in England during 2007-2013, compared to general population estimates. We examined variation by age, sex, deprivation, and time following presentation. FINDINGS: Of 250,606 patients presenting with fatigue, 12-month cancer risk exceeded 3% in men aged 65 and over and women aged 80 and over, and 6% in men aged 80 and over. Nearly half (47%) of cancers were diagnosed within 3 months from first fatigue presentation. Site-specific cancer risk was higher than the general population for most cancers studied, with greatest relative increases for leukaemia, pancreatic and brain cancers. CONCLUSIONS: In older patients, new-onset fatigue is associated with cancer risk exceeding current thresholds for urgent specialist referral. Future research should consider how risk is modified by the presence or absence of other signs and symptoms. Excess cancer risk wanes rapidly after 3 months, which could inform the duration of a 'safety-netting' period. Fatigue presentation is not strongly predictive of any single cancer, although certain cancers are over-represented; this knowledge can help prioritise diagnostic strategies.en_GB
dc.description.sponsorshipCancer Research UKen_GB
dc.description.sponsorshipInternational Alliance for Cancer Early Detectionen_GB
dc.format.extent1-10
dc.identifier.citationPublished online 18 February 2022en_GB
dc.identifier.doihttps://doi.org/10.1038/s41416-022-01733-6
dc.identifier.grantnumberC18081/A18180en_GB
dc.identifier.urihttp://hdl.handle.net/10871/128913
dc.identifierORCID: 0000-0002-2228-2374 (Price, Sarah)
dc.identifierScopusID: 57195915869 (Price, Sarah)
dc.identifierResearcherID: D-2641-2016 (Price, Sarah)
dc.language.isoenen_GB
dc.publisherSpringer Nature/Cancer Research UKen_GB
dc.relation.urlhttps://www.ncbi.nlm.nih.gov/pubmed/35181753en_GB
dc.rights© The Author(s) 2022. Open Access: This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.en_GB
dc.subjectClinical Researchen_GB
dc.subjectRare Diseasesen_GB
dc.subjectCanceren_GB
dc.subjectHealth Servicesen_GB
dc.subject7.3 Management and decision makingen_GB
dc.subjectCanceren_GB
dc.titleRisk of cancer following primary care presentation with fatigue: a population-based cohort study of a quarter of a million patients.en_GB
dc.typeArticleen_GB
dc.date.available2022-03-02T10:47:21Z
dc.identifier.issn0007-0920
exeter.place-of-publicationEngland
dc.descriptionThis is the final version. Available from Springer Nature via the DOI in this record. en_GB
dc.descriptionData availability: The data used in this study were accessed through the CPRD, and is subject to protocol approval by an Independent Scientific Advisory Committee, and therefore cannot be directly shared.en_GB
dc.identifier.eissn1532-1827
dc.identifier.journalBritish Journal of Canceren_GB
dc.relation.ispartofBr J Cancer
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/en_GB
dcterms.dateAccepted2022-02-01
rioxxterms.versionVoRen_GB
rioxxterms.licenseref.startdate2022-02-18
rioxxterms.typeJournal Article/Reviewen_GB
refterms.dateFCD2022-03-02T10:40:57Z
refterms.versionFCDVoR
refterms.dateFOA2022-03-02T10:49:42Z
refterms.panelAen_GB
refterms.dateFirstOnline2022-02-18


Files in this item

This item appears in the following Collection(s)

Show simple item record

© The Author(s) 2022. Open Access: This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
Except where otherwise noted, this item's licence is described as © The Author(s) 2022. Open Access: This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.